The company DoMore Diagnostics has its origins in the Research Council of Norway’s strategic ICT flagship projects, where DoMore! was one of three major groundbreaking initiatives.
DoMore Diagnostics AS streamlines and provides decision support for cancer diagnostics and has now received a significant grant from the European Innovation Council (EIC). The EIC recently announced funding of up to 10 million euros (approximately 115 million Norwegian kroner) to Oslo-based DoMore Diagnostics AS for developing new technology capable of analyzing cancer tumors, providing precise prognoses, and personalizing treatment. Leveraging artificial intelligence and digital biomarkers, they aim to extract and utilize information from tumor tissue that is not visible to the human eye. The EIC is a funding program under the EU’s Horizon Europe framework, supporting radical and pioneering innovation and technology.
Leveraging artificial intelligence and digital biomarkers, they aim to extract and utilize information from tumor tissue that is not visible to the human eye. The EIC is a funding program under the EU’s Horizon Europe framework, supporting radical and pioneering innovation and technology.